Thromboxane receptor

The thromboxane receptor is a protein that in humans is encoded by the TBXA2R gene. This receptor is a member of the G protein-coupled receptor superfamily and is specifically responsive to thromboxane A2, a potent mediator of platelet aggregation and vasoconstriction. The receptor plays a crucial role in the pathophysiology of several cardiovascular diseases, including stroke, myocardial infarction, and hypertension.

Function

The thromboxane receptor mediates the action of thromboxane A2, which is produced by the enzyme thromboxane-A synthase from prostaglandin H2. Binding of thromboxane A2 to this receptor induces various responses including platelet aggregation, vasoconstriction, and proliferation of vascular smooth muscle cells, contributing to the formation of atherosclerotic plaques and cardiovascular disease.

Gene

The TBXA2R gene is located on the short arm of chromosome 19 (19p13.3) in humans. It encodes a protein of 343 amino acids which is widely expressed in various tissues, including the lung, liver, and spleen, with particularly high expression in platelets.

Clinical Significance

Alterations in the expression or function of the thromboxane receptor have been implicated in a variety of clinical conditions. Antagonists of this receptor are being studied for their potential benefits in treating cardiovascular diseases by reducing thrombotic events. Additionally, genetic polymorphisms in TBXA2R have been associated with an increased risk of myocardial infarction and stroke in certain populations.

Pharmacology

Several thromboxane receptor antagonists have been developed to inhibit the effects of thromboxane A2. These antagonists are being investigated for their therapeutic potential in reducing the risk of thrombosis and its complications in cardiovascular diseases.

See also

• Thromboxane
• G protein-coupled receptor
• Cardiovascular disease
• Platelet